参考文献/References:
[1] 杨跃进，赵杰．血管内超声和光学相干断层成像在冠状动脉介入治疗中的应用价值[J]．中国循环杂志,2011,26(6):401-403.
[2] van der Meer FJ,Faber DJ,Perrée J, et al.Quantitative optical coherence tomography of arterial wall components[J].Lasers Med Sci,2005,20(1):45-51.
[3] Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient a call for new definitions and risk assessment strategies: part I [J]. Circulation, 2003, 108(14):1664-1672.
[4] 中华医学会心血管病学分会介入心脏病学组,心血管病影像学.光学相干断层成像技术在冠心病介入诊疗领域的应用中国专家建议[J].中华心血管病杂志, 2017,45(1): 5-12 .
[5] Dai J,Tian J,Hou J,et al.Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome:an optical coherence tomography study[J]. Atherosclerosis, 2016,247:111-117.
[6] Fujii K, Hao H, Shibuya M, et al. Accuracy of OCT, grayscale IVUS, and their combination for the diagnosis of coronary TCFA: an ex vivo validation study[J]. JACC Cardiovasc Imaging,2015,8(4):451-460.
[7] Panh L, Lairez O, Ruidavets JB,et al.Coronary artery calcification: from crystal to plaque rupture[J].Arch Cardiovasc Dis,2017,110(10):550-561.
[8] Rzeczuch K,Szajn G,Jankowska E,et al.Borderline coronary lesions may lead to serious coronary events—long-term outcome in 65 conservatively treated patients[J].Kardiol Pol,2005,63 (7):50-56.
[9] Arbustini E,Dal B , Morbini P,et al.Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction[J].Heart,1999,82(3):269-272.
[10] Yahagi K,Kolodgie FD,Lutter C,et al.Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes[J]. Arterioscler Thromb Vasc Biol,2017,37:191-204.
[11] Jia H,Abtahian F,Aguirre AD,et al.In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography[J]. J Am Coll Cardiol,2013,62(19):1748-1758.
[12] Huang J,Belmadani K,Chatot M,et al.Clinical significance of optical coherence tomography-guided angioplasty on treatment selection[J].Exp Ther Med,2018,16(2):483-492.
[13] Meneveau N,Souteyrand G,Motreff P,et al. Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome: results of the multicenter, randomized DOCTORS study (does optical coherence tomography optimize results of stenting)[J]. Circulation,2016,134(13):906-917.
[14] Gonzalo N,Serruys PW,Okamura T,et al.Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach[J]. Heart,2009,95:1895-1896.
[15] Teijeiro Mestre R,Alegría-Barrero E,di Mario C. Microchannels in recent chronic total occlusions assessed with frequency-domain optical coherence tomography[J]. Rev Esp Cardiol (Engl Ed),2013,66(11):907.
[16] Biscaglia S,Campo G,Tebaldi M, et al. Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study):a two-centre prospective comparison[J],Int J Cardiovasc Imaging,2016,32(2):211-223.
[17] Li H,Rha SW,Choi CU. Optical coherence tomography and stent boost imaging guided bioresorbable vascular scaffold overlapping for coronary chronic total occlusion lesion[J]. Yonsei Med J,2017,58(5):1071-1074.
[18] Farooq V, Serruys PW, Heo JH, et al.New insights into the coronary artery bifurcation hypothesis-generating concepts utilizing 3-dimensional optical frequency domain imaging[J]. JACC Cardiovasc Interv,2011,4(8):921-931.
[19] Karacsonyi J,Alaswad K,Jaffer FA,et al.Use of intravascular imaging during chronic total occlusion percutaneous coronary intervention: insights from a contemporary multicenter registry[J].J Am Heart Assoc,2016,5 (8):B231-B231.
[20] Hu S,Zhu Y,Zhang Y,et al.Management and outcome of patients with acute coronary syndrome caused by plaque rupture versus plaque erosion: an?intravascular optical coherence tomography study[J].J Am Heart Assoc Cardiovasc Cerebrovasc Dis,2017,6(3):e004730.
[21] Jia H,Dai J,Hou J,et al.Effective anti-thrombotic therapy without stenting:intravascular optical coherence tomography-based management in plaque erosion(the EROSION study)[J].Eur Heart J, 2016,38(11):792.
[22] Libby P.Superficial erosion and the precision management of acute coronary syndromes:not one-size-fits-all[J].Eur Heart J,2017,38(11):801-803.
[23] Li H,Fu DG,Liu FY,et al.Evaluation of related factors, prediction and treatment drugs of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction after direct PCI[J].Exp Ther Med,2018,15(4):3940-3946.
[24] Negishi Y, Ishii H,Suzuki S, et al.The combination assessment of lipid pool and thrombus by optical coherence tomography can predict the filter no-reflow in primary PCI for ST elevated myocardial infarction[J].Medicine,2017,96(50):e9297.
[25] Rathod KS,Hamshere SM,Jones DA,et al. Intravascular ultrasound versus optical coherence tomography for coronary artery imaging - apples and oranges?[J]. Interv Cardiol,2015,10(1):8-15.
[26] Nakamura T, Okamura T, Fujimura T,et al. Serial changes in the three-dimensional aspect of the side-branch ostium jailed by a drug-eluting stent assessed by optical coherence tomography[J].Int J Cardiovasc Imaging,2017,33(6):797-806.
[27] Onuma Y, Grundeken MJ, Nakatani S, et.al. Serial 5-year evaluation of side branches jailed by bioresorbable vascular scaffolds using 3-dimensional optical coherence tomography: insights from the ABSORB cohort B trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions)[J].Circ Cardiovasc Interv,2017,10(9):e004393.
[28] Imanaka T,Fujii K,Hao H,et al.Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation:optical coherence tomography and histopathology validation study[J]. Int J Cardiol,2016,221:1043-1047.
[29] Finn AV,Joner M,Nakazawa G,et al.Pathological correlates of late drug-eluting stent thrombosis:strut?coverage?as a?marker?of?endothelialization[J].Digest World Core Med J,2007,115 (18):2435-2441.
[30] Tada T,Kadota K,Habara S.The association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions:a comparison between balloon angioplasty,paclitaxel-coated balloon dilatation,and drug-eluting stent implantation[J]. Eur Heart J Cardiovasc Imaging,2015,62(18):B22-B23.
相似文献/References:
[1]郑晓雪 季福绥.急性冠脉综合征患者发生急性肾损伤的临床进展[J].心血管病学进展,2019,(5):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
ZHENG Xiaoxue,JI Fusui.Acute Kidney Injury in Patients with Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(6):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
[2]周小琳 何泉.替格瑞洛在急性冠脉综合征合并慢性肾脏病患者中的应用研究进展[J].心血管病学进展,2019,(5):718.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.014]
ZHOU Xiaolin,HE Quan.Ticagrelor in Acute Coronary Syndrome with Chronic Kidney Disease[J].Advances in Cardiovascular Diseases,2019,(6):718.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.014]
[3]吕俊兴 许海燕.急性冠脉综合征危险评分的研究进展[J].心血管病学进展,2019,(9):1224.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.010]
LU Junxing,XU Haiyan.Risk Scores of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(6):1224.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.010]
[4]吕颖 胡思宁 于波 贾海波.斑块侵蚀发病机制的最新研究进展[J].心血管病学进展,2020,(1):74.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.020]
LU Ying,HU Sining,YU Bo,et al.Pathogenic Mechanisms of Plaque Erosion[J].Advances in Cardiovascular Diseases,2020,(6):74.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.020]
[5]段继坤,林志,杨帆,等.斑块侵蚀引起的急性冠脉综合征的研究新进展[J].心血管病学进展,2020,(3):281.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.016]
DUAN Jikun,LIN Zhi,YANG Fan,et al.Acute Coronary Syndrome Caused by Plaque Erosion[J].Advances in Cardiovascular Diseases,2020,(6):281.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.016]
[6]陈凯磊 胡闻竹 苏冠华.P2Y12抑制剂与癌症风险的相关性研究进展[J].心血管病学进展,2020,(8):798.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.004]
CHEN Kailei,HU Wenzhu,SU Guanhua.Advances in Studies on the Correlation between P2Y12 Inhibitors and Cancer Risk[J].Advances in Cardiovascular Diseases,2020,(6):798.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.004]
[7]田婷 罗俊一 杨毅宁.一种罕见的冠状动脉异常——编织样冠状动脉[J].心血管病学进展,2020,(9):943.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.014]
TIAN Ting,LUO Junyi,YANG Yining.An Extremely Rare Anomaly of Coronary Artery[J].Advances in Cardiovascular Diseases,2020,(6):943.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.014]
[8]肖雨尘 赵仙先 马丽萍.急性冠脉综合征患者提前停服替格瑞洛现象的研究进展[J].心血管病学进展,2020,(11):1120.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
Acute Coronary Syndrome.Premature Ticagrelor Discontinuation in Patients with[J].Advances in Cardiovascular Diseases,2020,(6):1120.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[9]冯洁渊 .中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值与急性冠脉综合征的关系研究进展[J].心血管病学进展,2020,(12):1276.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.013]
FENG Jieyuan.The Relationship Between Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio and Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2020,(6):1276.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.013]
[10]马越 宋雷 乔树宾.腔内影像学在冠状动脉支架内再狭窄中应用的研究进展[J].心血管病学进展,2021,(3):202.[doi:10.16806/j.cnki.issn.1004-3934.20.03.003]
MA Yue,SONG Lei,QIAO Shubin.Application of Intravascular Imaging in Coronary Artery In-stent Restenosis[J].Advances in Cardiovascular Diseases,2021,(6):202.[doi:10.16806/j.cnki.issn.1004-3934.20.03.003]